Teva Pharmaceuticals
TEVA
TEVA
576 hedge funds and large institutions have $14.7B invested in Teva Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 193 increasing their positions, 189 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 538 → 576 (+38)
2.56% more ownership
Funds ownership: 56.11% → 58.67% (+2.6%)
2% more repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 189
Holders
576
Holding in Top 10
36
Calls
$727M
Puts
$402M
Top Buyers
| 1 | +$424M | |
| 2 | +$167M | |
| 3 | +$150M | |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$97.5M |
| 5 |
PC
PointState Capital
New York
|
+$83M |
Top Sellers
| 1 | -$174M | |
| 2 | -$116M | |
| 3 | -$114M | |
| 4 |
Neuberger Berman Group
New York
|
-$85.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$59.7M |